While unapproved home tests for chlamydia and gonorrhea have already been on the market, The Simple 2 Test is the first to go through the FDA’s approval process.

The FDA's first-ever approval of an at-home test for chlamydia and gonorrhea could help get the skyrocketing STI epidemic under control in the U.S.

Patients had better linkage to care for HIV and HIV was more frequently diagnosed when it was tested alongside other sexually ...

STI screening beyond the clinic walls raises some issues that should be factored into the screening delivery. In contrast to clinic-based care, screening outside of clinic settings may not allow for a ...

GlobalData analysis reveals that in H1 2025, US hospital sales volume for chlamydia/gonorrhoea tests decreased by 1.7% versus ...

Medical self-tests sold online and in pharmacies are convenient but often lack clear instructions and conflict with existing ...

The U.S. Food and Drug Administration on Nov. 15, 2023, said it has granted marketing authorization for the first at-home test for chlamydia and gonorrhea. The tests from LetsGetChecked will be ...

The DOD does require annual chlamydia testing, which often includes a panel of tests for other STIs such as gonorrhea and syphilis, but the testing is only required for women under 25 years of age.

The preferred site for chlamydia screening was the Indian Health Service Clinic (n = 114; 70%), but 79 women (41%) would accept a C. trachomatis test at a nonclinical testing site.